SCHEMBL20425534

SCHEMBL20425534

C[C@H](N)C(=O)Oc1ccc2ccc3cccc4ccc1c2c34

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.42
▸ HPGD P15428 4/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ HSD17B10 Q99714 4/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CYP1A2 P05177 3/20 0.37
▸ GLA P06280 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ NCEH1 Q6PIU2 4/20 0.37
▸ PGR P06401 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27610832 0.88 KMT2A (0.39) ALDH1A1HPGDKDM4EMAPTKMT2A
SCHEMBL19999169 0.82 KMT2A (0.41) ALDH1A1HPGDKDM4EMAPTKMT2A
SCHEMBL246709 0.80 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL8458747 0.80 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL4600933 0.80 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL3795231 0.79 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EMAPTKMT2A
SCHEMBL21599112 0.79 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EMAPTKMT2A
SCHEMBL9561301 0.78 KMT2A (0.47) ALDH1A1HPGDKDM4EMAPTKMT2A
SCHEMBL5246333 0.77 KMT2A (0.50) ALDH1A1HPGDKDM4EMAPTKMT2A
SCHEMBL27625620 0.77 KMT2A (0.46) ALDH1A1HPGDKDM4EMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114761026-A Compositions and methods for in vivo synthesis of non-native polypeptides 斯克利普斯研究所 2022-07-15 — — CN disclosed
EP-3938051-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF Aileron Therapeutics, Inc. (US) 2022-01-19 — — EP disclosed
WO-2021072167-A1 COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES THE SCRIPPS RESEARCH INSTITUTE (US) 2021-04-15 — — WO disclosed
WO-2020190742-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF AILERON THERAPEUTICS, INC. (US) 2020-09-24 — — WO disclosed
WO-2018140799-A2 NEUROTROPHIN MUTANTS AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS HORACIO URI SARAGOVI (CA) 2018-08-02 — — WO disclosed
Send feedback